Kinin-B2 Receptor Activity Determines the Differentiation Fate of Neural Stem Cells
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
31/10/2013
31/10/2013
2012
|
Resumo |
Bradykinin is not only important for inflammation and blood pressure regulation, but also involved in neuromodulation and neuroprotection. Here we describe novel functions for bradykinin and the kinin-B2 receptor (B2BkR) in differentiation of neural stem cells. In the presence of the B2BkR antagonist HOE-140 during rat neurosphere differentiation, neuron-specific beta 3-tubulin and enolase expression was reduced together with an increase in glial protein expression, indicating that bradykinin- induced receptor activity contributes to neurogenesis. In agreement, HOE-140 affected in the same way expression levels of neural markers during neural differentiation of murine P19 and human iPS cells. Kinin-B1 receptor agonists and antagonists did not affect expression levels of neural markers, suggesting that bradykinin-mediated effects are exclusively mediated via B2BkR. Neurogenesis was augmented by bradykinin in the middle and late stages of the differentiation process. Chronic treatment with HOE-140 diminished eNOS and nNOS as well as M1-M4 muscarinic receptor expression and also affected purinergic receptor expression and activity. Neurogenesis, gliogenesis, and neural migration were altered during differentiation of neurospheres isolated from B2BkR knock-out mice. Whole mount in situ hybridization revealed the presence of B2BkR mRNA throughout the nervous system in mouse embryos, and less beta 3-tubulin and more glial proteins were expressed in developing and adult B2BkR knock-out mice brains. As a underlying transcriptional mechanism for neural fate determination, HOE-140 induced up-regulation of Notch1 and Stat3 gene expression. Because pharmacological treatments did not affect cell viability and proliferation, we conclude that bradykinin-induced signaling provides a switch for neural fate determination and specification of neurotransmitter receptor expression. National Institutes of Health National Institutes of Health [1-DP2-OD006495-01] Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9] Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa [2011.1.9333.1.3] Provosts Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa NAPNA-USP, Brazil NAPNAUSP, Brazil International Rett Syndrome Foundation [2517] International Rett Syndrome Foundation Emerald Foundation Emerald Foundation California Institute for Regenerative Medicine Grant California Institute for Regenerative Medicine Grant [TR2-01814] Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Conselho Nacional de Desenvolvimento Cientifico e Tecnologico |
Identificador |
JOURNAL OF BIOLOGICAL CHEMISTRY, BETHESDA, v. 287, n. 53, p. 44046-44061, DEC 28, 2012 0021-9258 http://www.producao.usp.br/handle/BDPI/37090 10.1074/jbc.M112.407197 |
Idioma(s) |
eng |
Publicador |
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC BETHESDA |
Relação |
Journal of Biological Chemistry |
Direitos |
closedAccess Copyright AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC |
Palavras-Chave | #EMBRYONAL CARCINOMA-CELLS #NITRIC-OXIDE #ADULT NEUROGENESIS #PROGENITOR CELLS #NEURONAL DIFFERENTIATION #INHIBITING APOPTOSIS #SUBVENTRICULAR ZONE #ALZHEIMERS-DISEASE #ISCHEMIC-STROKE #NERVOUS-SYSTEM #BIOCHEMISTRY & MOLECULAR BIOLOGY |
Tipo |
article original article publishedVersion |